JACOBS LEVY EQUITY MANAGEMENT, INC
Position in SRPT — Sarepta Therapeutics, Inc.
CIK 884414
FLORHAM PARK, NJ
Position in SRPT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,108,581
-$3,800,135 QoQ
Shares Held
372,637
-32.7% QoQ
Ownership
0.353%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
20 quarters on record
Voting authority
Sole 88.31114462600333.ToString("F0")%
Shared 0.ToString("F0")%
None 11.688855373996677.ToString("F0")%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $705,903,019 across 86 Biotechnology names. SRPT ranks #14 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
214,160 | $165,468,582 | |
| 2 | INCY |
Incyte Corp
|
1,717,978 | $161,696,089 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
212,204 | $70,211,937 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
789,429 | $51,020,796 | |
| 5 | RARE |
Ultragenyx Pharmaceutical Inc.
|
1,431,071 | $29,980,937 | |
| 6 | EXEL |
Exelixis, Inc.
|
425,982 | $18,270,367 | |
| 7 | AUPH |
Aurinia Pharmaceuticals Inc.
|
1,097,189 | $16,260,340 | |
| 8 | ARVN |
Arvinas, Inc.
|
1,441,521 | $15,280,122 |
All Filings in SRPT
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,108,581 | 372,637 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,908,716 | 553,379 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,055,118 | 262,331 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $4,181,514 | 244,533 | Shares | Sole | 2025-08-14 | |
| 2024-09-30 | $94,147,702 | 753,845 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $109,084,464 | 690,408 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $75,039,806 | 579,637 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $44,271,205 | 459,102 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $48,179,616 | 397,456 | Shares | Sole | 2023-11-17 | |
| 2023-06-30 | $51,027,019 | 445,573 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $66,433,508 | 481,996 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $61,667,251 | 475,901 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $55,512,414 | 502,193 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $32,668,317 | 435,810 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $34,220,075 | 438,045 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $38,607,496 | 428,734 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $9,043,156 | 97,785 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,225,933 | 92,950 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $6,632,946 | 88,997 | Shares | Sole | 2021-05-17 | |
| 2020-06-30 | $471,880 | 2,943 | Shares | Sole | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||